A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is a randomized, double-blind, multicenter, placebo-controlled Phase III clinical study, consisting of a 4-week screening period, a 24-week core treatment period, a 24-week maintenance treatment period, and an 8-week safety follow-up period. It is planned to include 150 adult subjects with psoriatic arthritis.
Epistemonikos ID: e47586407ff6518b149184742b52b990a24651a6
First added on: Nov 01, 2024